Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Matthias O. Schmitt"'
Autor:
Cyprian R. Roman, Matthias O. Schmitt, Clemens F. Leypold, Siegfried Schneider, Frank W. Heinemann
Publikováno v:
Journal of Chemical Crystallography. 43:213-222
The molecular and crystal structures of α-6-deoxy-β-5-oxytetracycline (doxycycline) hydrochloride, of tetracycline hydrochloride and tetracycline hexahydrate were re-determined. The crystal structures of 6-deoxy-6-dimethyl-tetracycline (sancycline)
Publikováno v:
Zeitschrift für Physikalische Chemie. 221:235-271
In a recent publication (M. O. Schmitt and S. Schneider [1], Z. Phys. Chem. 220 (2006) 441), we have shown that the principal component analysis of the sets of absorption spectra recorded during a titration cycle (pH2 ↔ pH11) generally yields more
Publikováno v:
Zeitschrift für Physikalische Chemie. 220:441-475
Summary The UV/vis absorption spectra recorded during titration experiments (pH2 ↔ pH11, ΔpH ∼ 0.33) were subjected to a principal component analysis. The aim was to determine by means of the program SPECFIT the number of significant components
Autor:
Siegfried Schneider, Markus Reiher, Clemens F. Leypold, Pavel Matousek, G. Brehm, Michael Towrie, Matthias O. Schmitt
Publikováno v:
Physical Chemistry Chemical Physics. 5:1149-1157
IR and Raman spectra (λex = 1064, 400 and 280 nm) were recorded for solutions of tetracycline and several derivatives in acidified and alkaline H2O and D2O, respectively. Based on the observed resonance enhancement, an empirical assignment of most o
Autor:
Matthias O. Schmitt
Publikováno v:
Results in Mathematics. 39:91-98
We prove that the tensor product of the spaces \(BV_{{X}_{1}},\ldots,BV_{{X}_{s}}\) is not dense in the space \(BV_{{X}_{1}},\times\ldots\times {X}_{s}\), equipped with the usual BV-norm. After that we give an approximation result for functions of BV
Autor:
Klaus Überla, Klaus Korn, van Vaerenbergh K, Thomas Harrer, Anne-Mieke Vandamme, Hauke Walter, Matthias O. Schmitt, Christiane Paatz, Brigitte Moschik, Barbara Schmidt
Publikováno v:
AIDS. 14:1731-1738
Background: Resistance against protease inhibitors (PI) can either be analysed genotypically or phenotypically. However, the interpretation of genotypic data is difficult, particularly for PI, because of the unknown contributions of several mutations
Autor:
Joachim R. Kalden, Andreas Goldwich, Matthias O. Schmitt, Irina Graedner, Michael Bäuerle, Ellen G. Harrer, Thomas Harrer
Publikováno v:
AIDS. 14:653-658
OBJECTIVE The reverse transcriptase (RT) M184V mutation within the HLA-A2-restricted HIV-1 cytotoxic T lymphocyte (CTL) epitope VL9 (VIYQYMDDL; RT 179-187) not only induces drug escape against lamivudine but also abolished recognition by a CTL clone
Autor:
Pavel Matousek, Siegfried Schneider, Markus Reiher, Matthias O. Schmitt, Michael Towrie, G. Brehm
Publikováno v:
Photochemicalphotobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology. 2(11)
The fluorescence spectra of acidified aqueous solutions of tetracycline (tcH3+) exhibit three components with slightly different degrees of anisotropy: the 'blue' component (lambdad approximately equal to 475 nm) decays on the timescale of a few pico
Autor:
Monika Tschochner, P. Löw, Klaus Überla, Eva Schwingel, Matthias O. Schmitt, Klaus Korn, Barbara Schmidt, Martin Helm, Thomas Harrer, Hauke Walter
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 31(2)
The number of HIV-1-infected patients harboring multidrug-resistant viruses is increasing. Since new antiretroviral drugs with favorable resistance profiles are limited, innovative strategies are urgently needed. Treatment interruptions can lead to a
Autor:
W. Rödl, J. Schwab, Joachim R. Kalden, Thomas Harrer, H. Parsch, W. G. Struff, M. Gramatzki, Matthias O. Schmitt, Joachim H. Ficker
Publikováno v:
Scopus-Elsevier
In a pilot study the safety and therapeutic effects of an immunostimulatory intralymphatic treatment with natural human interleukin-2 (IL-2) in combination with zidovudine were evaluated in nine patients with AIDS. Therapy with IL-2 consisted of one